I would not count on the IPO to raise the NUGX price from 0.3/0.7 to 10 dollars. There is no particular reason for NUGX to trade at the same price than NGIO due to shares conversion IMO, except if it is up-listed. Maybe I miss something… But in any case, it should slow down GNBT dilution.
Hopefully, the share price will move following positive trials results, soon!
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links